Characteristic findings of cervical Papanicolaou tests from transgender patients on androgen therapy: Challenges in detecting dysplasia

Adkins, Brian D.; Barlow, Andrew; Jack, Annie; Schultenover, Stephen J.; Desouki, Mohamed Mokhtar; Coogan, Alice; Weiss, Vivian L.

doi:10.1111/cyt.12525

Cited by 27 publications

(37 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In another US study, 3 64.3% of TM were up to date with screening recommendations as opposed to 73.5% of cisgender women. Additionally, TM have more inadequate Pap test results due to cytomorphological changes (atrophy) associated with androgen therapy 20,21 . The androgenic effect on genital tract, with tissue epithelial atrophy and tissue shrinkage, results in speculum insertion and cervical screening test collection being more uncomfortable and indeed painful.…”

Section: Are Transgender Men With a Cervix Exposed To Hpv And Cervicamentioning

confidence: 99%

“…Intervention research shows that training on Lesbian, Gay, Bisexual and Transgender+ (LGBT+, ‘with the “+” indicating inclusion of all sexual and gender minority identities’) topics as short as half a day for fifth‐year undergraduate students improved their confidence clinically to assess a transgender patient from 35 to 84% 25 . Cytologists need to be aware of the particular features of dysplasia in atrophic cervical cells, to avoid over‐ and under‐diagnosis 21 …”

Section: Recommendations For Screening Programmes and Healthcare Profmentioning

confidence: 99%

“…A specific opt‐in procedure should be foreseen to allow inclusion in the target population for cervical cancer screening for TM with a cervix. This includes TM who have not undergone hysterectomy as well as TM who have undergone supracervical hysterectomy 21 . TM who have undergone total hysterectomy should not be included unless there is a history of previous high‐grade CIN 18 .…”

Section: Recommendations For Screening Programmes and Healthcare Profmentioning

confidence: 99%

See 2 more Smart Citations

Cervical cancer prevention in transgender men: a review

Weyers

Garland

Cruickshank

et al. 2020

BJOG

View full text Add to dashboard Cite

There is increased awareness of transgender physical and mental health widely and in academic research. A significant proportion of transgender men will retain their cervix with an increased risk of cervical cancer. In this review of cervical cancer screening among transgender men, we try to estimate how many transgender men still have a cervix, understand to identify challenges and barriers to cervical screening and propose possible solutions. Organised cervical screening programmes need to consider the needs of this population, in particular the provision of HPV self‐sampling. Tweetable abstract Transgender men need access to cervical screening.

show abstract

Section: Are Transgender Men With a Cervix Exposed To Hpv And Cervicamentioning

confidence: 99%

Section: Recommendations For Screening Programmes and Healthcare Profmentioning

confidence: 99%

Section: Recommendations For Screening Programmes and Healthcare Profmentioning

confidence: 99%

See 1 more Smart Citation

Cervical cancer prevention in transgender men: a review

Weyers

Garland

Cruickshank

et al. 2020

BJOG

View full text Add to dashboard Cite

show abstract

“…Despite the recommendations for screening in TM, studies indicate that compared to cisgender women, TM report the following: higher rates of abnormal CCS results (Adkins et al, 2018), higher likelihood of not receiving CCS in their lifetime (37% TM vs. 10% cisgender women; Rahman et al, 2019), and lower likelihood of receiving regular CCS (56% TM vs. 72% cisgender women, p = .001; Kiran et al, 2019). Statistically significant discrepancies have been reported in screening status based on gender identities (p = .041).…”

mentioning

confidence: 99%

Bridging Barriers to Cervical Cancer Screening in Transgender Men: A Scoping Review

et al. 2020

View full text Add to dashboard Cite

Estimates of high-risk human papillomavirus (HPV) infection and susceptibility to HPV-related cancer in transgender men (TM) are comparable to prevalence rates found in cisgender women. Regular and thorough screening for cervical cancer is equally as crucial for TM as for cisgender women; however, despite continued risk for cervical cancer in TM and associated recommendations for screening, studies indicate disparities in rates of cervical cancer screening (CCS) in TM compared to cisgender women. The current scoping review explores TM’s knowledge and experiences of CCS and barriers to screening uptake in this population. A range of barriers were identified including the need for health-care services to provide care for TM within the context of a nonbinary approach to gender identity and health. Findings synthesized from relevant research studies ( n = 15; published 2008–2019) are presented, and recommendations are drawn from these findings to inform primary health-care providers’ clinical practice and care of TM.

show abstract

“…A existência de alta incidência de exames de Papanicolaou anormais nos homens transgêneros quando comparadas as mulheres cisgêneros de mesma faixa etária, principalmente quando está envolvida a utilização de terapia com andrógenos (Adkins et al, 2018), requer uma maior atenção por parte dos profissionais de saúde ao prestar assistência a esse público, visto que existe uma ausência de pesquisas clínicas associando o uso da testosterona ao risco de desenvolvimento de câncer cervical (Peitzmeier et al, 2017) e diretrizes especificas para triagem nesses indivíduos.…”

Section: Rastreamento Do Câncer Cervical Em Homens Transgênerosunclassified

Exame de Papanicolaou e câncer cervical em homens transgêneros: revisão integrativa

Araújo

Santos

Silva

et al. 2021

RSD

View full text Add to dashboard Cite

Introdução: O exame de Papanicolaou é o principal método de rastreamento para o câncer do colo do útero, que pode acometer os homens transgêneros que apresentam esse órgão. Objetivo: Destacar a importância do exame citopatológico no combate ao câncer cervical em homens transgêneros. Metodologia: Trata-se de uma revisão integrativa da literatura de cunho descritivo e abordagem qualitativa, realizada nas bases SciELO, PUBMED, MEDLINE, LILACS, BVS e Science Direct, utilizando os descritores “Transgender Persons”, “Uterine Cervical Neoplasms” e “Papanicolaou Test”. Foram incluídos artigos de 2015 a 2020 que abordam sobre o exame de Papanicolaou, e o câncer do colo do útero ou lesões precursoras do câncer em homens transgêneros. A análise ocorreu através de leitura crítica e categorização temática. Resultados e discussão: Foram encontrados oito artigos que originaram três categorias: Rastreamento do câncer cervical em homens transgêneros, histórico relacionado ao exame de Papanicolaou e percepções sobre o rastreamento do câncer cervical. Assim, constatou-se que os homens transgêneros não realizam rastreamento do câncer cervical como as mulheres cisgêneros e enfrentam desafios únicos no exame de Papanicolaou, pertinentes a cada realidade, levando-os a buscar alternativas que minimizem seus desconfortos. Conclusão: Os dados revelam a importância do exame de Papanicolaou no rastreamento do câncer cervical em homens transgêneros, visto que comparado a meios alternativos buscados, o mesmo é o mais confiável atualmente. Ainda, reforçam a necessidade de conhecimento para um rastreamento de forma individualizada nesse público.

show abstract

Characteristic findings of cervical Papanicolaou tests from transgender patients on androgen therapy: Challenges in detecting dysplasia

Cited by 27 publications

References 12 publications

Cervical cancer prevention in transgender men: a review

Cervical cancer prevention in transgender men: a review

Bridging Barriers to Cervical Cancer Screening in Transgender Men: A Scoping Review

Exame de Papanicolaou e câncer cervical em homens transgêneros: revisão integrativa

Contact Info

Product

Resources

About